GoSilico's founder team

Stop Experimenting. GoSilico.

About the GoSilico company

scroll for more

About the GoSilico company

GoSilico digitalizes biopharmaceutical downstream process development with computer simulation. Biopharmaceutical companies, CDMOs and vendors all over the globe use our ChromX software and rely on our unique simulation-based development approach.

The future is digital: Mission and vision


It is our mission to accelerate downstream process development with computer simulation. Our revolutionary ChromX simulation technology paves the way towards digitalized downstream process development. The benefits are manifold and massive: higher cost efficiency, reduced time-to-market, increased process understanding, better knowledge management – all in line with growing regulatory demands on Quality-by-Design.


The future of biopharmaceutical process development is driven by in silico solutions. It is only a matter of time until downstream process development and regulatory approval in life sciences will be compelled to involve computer simulation. We provide the tools to master this digital transition.

A strong industrial community backs the ChromX technology

Founded in 2016, today GoSilico serves more than half of the world’s top 10 leading biopharmaceutical companies. Also, numerous vendors and CDMOs digitalize their industrial downstream development using ChromX. Furthermore, its academic version is used in more than 40 countries, enabling academic researchers and students all over the globe to simulate liquid chromatography on the computer and to educate the workforce of the future.

GoSilico customer logos all

From university project to international player

GoSilico was founded in 2016 as a spin-off of Karlsruhe Institute of Technology (KIT) by Teresa Baumann, Tobias Hahn, Thiemo Huuk and Jürgen Hubbuch. From 2011 to 2015, the technology was developed during the PhD of the co-founders in close collaboration with large biopharmaceutical companies such as Roche Diagnostics GmbH. At that time, ChromX was intended primarily as an academic research tool, but industrial interest quickly grew. Once they had finished their PhDs, the founders established GoSilico in Karlsruhe, Germany. To meet the overwhelming interest of the biopharmaceutical industry, the founders quickly assembled a world-class team of experts. GoSilico and its simulation technology soon became the benchmark for downstream process simulations in the biopharmaceutical industry.

GoSilico’s founders – the pioneers of in silico process development

We are firmly convinced that the future of biopharmaceutical process development will be driven by in silico solutions. It is not only our profession but also our biggest passion to enable the digital transformation of process development.

GoSilico Founder and CEO Dr. Tobias Hahn


developed the prototype of the ChromX software during his PhD in Bioengineering. In this, he greatly benefitted from his experience in software development, which he had gained during his previous studies in applied mathematics. Tobias supervises the product development and service offers at GoSilico.

Dr. Thiemo Huuk, founder and CEO of GoSilico

Dr. Thiemo Huuk (CEO)

studied biotechnology, followed by an industry-oriented PhD in Bioengineering. In his PhD, he applied ChromX in a collaboration project with Roche Diagnostics and gained extensive expertise in industrial downstream process development. Given his profound background in biotechnology, Thiemo is responsible for the acquisition of new customers.

Dr. Teresa Baumann, co-founder and COO at GoSilico

Dr. Teresa Baumann (COO)

holds a Diplom in Meteorology and a PhD in applied mathematics. Teresa is responsible for GoSilico’s compliance with the highest quality standards. With her profound simulation background, she also leads the marketing activities at GoSilico.

GoSilico associate and scietific advisor Prof. Juergen Hubbuch

Prof. Jürgen Hubbuch

is a professor of biopharmaceutical process engineering at KIT. With his creative and visionary mindset, he develops new technologies at his institute but also accompanies innovation processes in pharmaceutical companies. At GoSilico, Jürgen provides his industrial insight, expertise and vision as a scientific advisor.

Our core values drive your success

With our unique experience in implementing simulation tools in the biopharmaceutical industry, the manifold successful projects and a strong scientific background, we are your partner for digitalizing your downstream process development. We are committed to your success and support you wherever we can. Our activities are driven by our core values:

  • Passion for game-changing solutions to foster sustainable innovation.
  • Profound expertise and professionalism leading all our actions.
  • Reliable partnerships on our way together towards the goal.
  • Respect, trust and responsibility guiding our daily work.

Quality made in Germany

We are committed to providing simulation software of the highest quality and accuracy as well as effective services and an outstanding customer service. Our product and services are designed to be compliant with all relevant industry-specific expectations and standards.

We strive to continuously improve our product and services, our business processes and our organization with respect to our customers’ requirements and regulations. Since 2018, GoSilico has been ISO 9001:2015 certified in quality management as part of our intrinsic commitment to long-lasting success. We guarantee the highest quality expectations at all times – so we can become and stay one of your trustworthy and appreciated partners.

TÜV Certification ISO 9001

Do NOT follow this link or you will be banned from the site!